Terumo Corp ADR (TRUMY)
Terumo Corp ADR is a depositary receipt listed on OTC Markets that represents common stock of Terumo Corporation, a Japanese healthcare company headquartered in Tokyo. The underlying issuer develops, manufactures, and sells medical products and equipment in Japan and across international markets, including Europe, China, the United States, and wider Asia. Its operations are organized into three business segments: Cardiac and Vascular Company, Medical Care Solutions Company, and Blood and Cell Technologies Company.
Through these segments, Terumo supplies a broad range of medical technologies, including devices for cardiovascular and neurovascular procedures, infusion and monitoring products, blood management systems, and cell processing equipment. The company was founded in 1921 and was previously known as Sekisen Ken-onki Corporation before adopting its current name in 1974.
Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Analyst Target Rating | Overall Financial Health | Upcoming Dividend Ex-Date | Dividend Payment Date | Upcoming Dividend | Dividend Yield | Next Earnings Date | P/E Ratio | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Payout Ratio | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
OTC-TRUM.Y
|
$16.08
|
17.0% Upside
|
Fair
|
—
|
—
|
—
|
Great
|
—
|
—
|
—
|
0.0%
|
August 7, 2026
|
24.6x
|
2.1x
|
3.0x
|
20.317 B
|
21.579 B
|
11.3%
|
98.0%
|
10.0
|
30.4%
|
107.2%
|
